Nasdaq, Inc. (NDAQ)

Stalwart

FairStock Score: 60/100 — STEADY

Key Financials

Current Price$91.06
Market Cap$50.3B
P/E Ratio27.43
ROE16.2%
Dividend Yield1.28%
SectorFinancial Services

Strengths

Concerns

AI Analysis

Nasdaq presents an intriguing paradox—a quality business trading at a deeply unreasonable price. The company operates a digital toll booth on capital markets with genuine competitive advantages: its indices and data platforms have become indispensable infrastructure, generating sticky, recurring revenues. Q4 margins of 24.4% on $2.1B revenue demonstrate pricing power and operational leverage. Free cash flow of $1.7B validates the business model's cash-generative capacity. However, I must be candid about the valuation: at $88.05, Nasdaq trades at 71.6x EBITDA with a Graham Number of merely $20.96—implying a margin of safety of negative 320%. This isn't margin of safety; it's margin of recklessness. The P/E of 27.94 assumes perpetual growth that the data doesn't clearly support. While ROE of 15.25% is respectable and the Piotroski score of 8/9 suggests quality fundamentals, the capital intensity question looms: ROCE of 5.05% is disappointing, suggesting capital isn't being deployed efficiently. The D/E ratio of 0.78 is manageable but relevant given the elevated multiple. Nasdaq operates a business I'd happily own at the right price—perhaps at $35-40 with genuine margin of safety. Today's price reflects either irrational exuberance or a growth narrative I'm not seeing in the numbers. As Graham taught, price and value diverge; here they're strangers.

Bull Case

If capital markets activity accelerates and Nasdaq successfully expands fintech services internationally, the quality of recurring revenues could justify premium multiples. A $100+ price becomes defensible with sustained 10-12% organic growth and continued margin expansion through operating leverage.

Bear Case

Market consolidation pressures, regulatory scrutiny on index licensing, and recession-driven decline in IPO activity could compress revenues and expose the valuation as hubris. A regression to fair value near $45-50 is entirely plausible if growth disappoints.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer